Non-invasive growth CuraMedix focuses on non-invasive shockwave and EMTT therapies to treat musculoskeletal conditions, presenting a clear value proposition for clinics seeking alternatives to surgery and opportunities to upsell EMTT devices to pain management and sports medicine practices.

U.S. market leadership As a leading U.S. distributor of STORZ Medical shockwave and EMTT devices, CuraMedix has established a strong channel advantage that can be leveraged to target independent clinics, regional hospital networks, and specialty centers seeking reliable access to reputable equipment.

Growth through events Recent conference activity and a recurring focus on tissue regeneration indicate potential for partner-led education and training programs. Sales opportunities exist in sponsorships, clinical demonstrations, and clinician onboarding events to drive device adoption.

Product portfolio expansion With the MAGNETOLITH EMTT device launched and ongoing interest in EMTT technology, there is room to cross-sell complementary devices or bundles to existing customers, as well as pursue clinics expanding into regenerative and connective tissue therapies.

Market signals Underscored by a revenue range and active digital presence, there is potential to pursue strategic accounts in outpatient pain clinics, physical therapy networks, and chiropractors’ offices, focusing on ROI-driven justifications and patient outcomes to accelerate procurement.